Clinical Trials Sponsored by Daiichi Sankyo (China) Holdings Co., Ltd.

Total 127 results

Coherus Biosciences, Inc.
Daiichi Sankyo Co., Ltd.

Completed

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) (CHS-0214-02)

Rheumatoid Arthritis

United States, Spain, Israel, Belarus, Japan, Poland, Hungary, South Africa, Germany, Russian Federation, France, United Kingdom
Daiichi Sankyo Co., Ltd.
Quintiles, Inc.; CMIC Co, Ltd. Japan; Quintiles Malaysia Sdn. Bhd.

Completed

DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain

Japan
Keimyung University Dongsan Medical Center
Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company

Recruiting

Resolution of Thrombi in Left Atrial Appendage With Edoxaban (REFLEX)

Atrial Fibrillation | Left Atrial Appendage Thrombosis

Korea, Republic of
Coherus Biosciences, Inc.
Shire; Daiichi Sankyo Co., Ltd.

Completed

A Long Term Safety Extension Study (CHS-0214-05)

Rheumatoid Arthritis | Plaque Psoriasis

Japan
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Completed

A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction (ACCOAST)

Acute Coronary Syndromes

Israel, Italy, Germany, Belgium, Poland, France, Austria, Netherlands, Turkey, Hungary, Lithuania, Romania, Canada, Slovakia, Czech Republic, Finland, Latvia, Portugal, Sweden
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Completed

Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease (GENERATIONS)

Coronary Artery Disease

Netherlands, Sweden, United States, Ireland
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Completed

Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease (FEATHER)

Coronary Artery Disease

Sweden, Netherlands, United States, Ireland
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Terminated

Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI) (TRIGGER-PCI)

Coronary Artery Disease (CAD)

United States, Germany
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Completed

A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome

Acute Coronary Syndrome

China, Thailand, Taiwan, Korea, Republic of
Samsung Medical Center
Daiichi Sankyo Korea Co., Ltd.

Completed

Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes

Diabetes Mellitus | Prediabetic State

Korea, Republic of
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Terminated

Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes

Acute Coronary Syndromes

Germany
Eli Lilly and Company
Daiichi Sankyo Co., Ltd.

Completed

An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults

Anemia, Sickle Cell

United Kingdom
National Cancer Center Hospital East
Daiichi Sankyo Co., Ltd.

Recruiting

Phase 2 Study of T-DXd in the Neoadjuvant Treatment for Patients With HER2 Positive Gastric and GEJ Adenocarcinoma

Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

Japan
Seoul St. Mary's Hospital
Daiichi Sankyo Korea Co., Ltd.; Daewoong Pharmaceutical Co. LTD.

Unknown

Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension

Hypertension

Korea, Republic of
Seoul National University Bundang Hospital
Daiichi Sankyo Korea Co., Ltd.

Completed

Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic Significance

Hypertension | Ischemic Stroke

Korea, Republic of
Ludwig Institute for Cancer Research
Daiichi Sankyo Co., Ltd.; Austin Health

Completed

Safety and Bioimaging Trial of DS-8895a in Patients With Advanced EphA2 Positive Cancers (LUD2014-002)

Malignant Solid Tumor | Metastatic EphA2 Positive Cancer

Australia
Sung-Hwan Kim
Daiichi Sankyo Korea Co., Ltd.

Recruiting

Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis (ERTEMIS)

Stroke | Atrial Fibrillation | Mitral Valve Stenosis | Systemic Embolism

Korea, Republic of
Seoul National University Bundang Hospital
Daiichi Sankyo, Inc.; Daewoong Pharmaceutical Co. LTD.

Completed

Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan (ESPECIAL)

Hypertension | Chronic Kidney Disease | Microalbuminuria

Korea, Republic of
Eli Lilly and Company
Duke Clinical Research Institute; Daiichi Sankyo Co., Ltd.

Completed

A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects (TRILOGY ACS)

Acute Coronary Syndrome

Argentina, Brazil, Canada, Italy, China, Puerto Rico, Australia, Romania, Russian Federation, France, Germany, United States, Belgium, Bulgaria, Poland, Ukraine, United Kingdom, Colombia, Hungary, Philippines, Croatia, Denmark, India, Chil... and more
Translational Research Center for Medical Innovation...
Daiichi Sankyo Co., Ltd.

Completed

Exploratory Study for the Validity of QuQu Scale (QuQu)

Alzheimer Dementia

Japan
Royal Brompton & Harefield NHS Foundation Trust
Abbott Medical Devices; Daiichi Sankyo Co., Ltd.

Terminated

Direct Angioplasty for Non ST Elevation Acute Coronary Events: DANCE Pilot Study (DANCE)

Acute Coronary Syndrome

United Kingdom
Jonsson Comprehensive Cancer Center
Daiichi Sankyo Co., Ltd.; Translational Research in Oncology-U.S

Recruiting

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Invasive Breast Cancer | Stage II Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Hormone Receptor Positive Breast Carcinoma | Early-stage Breast Cancer | Stage III Breast Cancer

United States
Translational Research Center for Medical Innovation...
Daiichi Sankyo Co., Ltd.

Completed

Verification Study and Reactivity Study for the Validity of QuQu Scale (QuQu)

Alzheimer's Disease Dementia | Cognitive Concern Without Dementia

Japan
Sang Hyun Ihm, MD PhD
Daiichi Sankyo Korea Co., Ltd.; Daewoong Pharmaceutical Co. LTD.

Completed

Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPM (EARTH)

Hypertension

Korea, Republic of
Mitsukoshi Health and Welfare Foundation
Daiichi Sankyo Co., Ltd.; Ministry of Health, Labour and Welfare, Japan

Completed

Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)

Hyperlipidemia
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea; Daiichi Sankyo Korea Co., Ltd.

Completed

Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement (ADAPT-TAVR)

Aortic Valve Stenosis

Taiwan, Hong Kong, Korea, Republic of
Satoshi Shizuta
Daiichi Sankyo Co., Ltd.; Research Institute for Production Development

Completed

Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study (OAC-ALONE)

Coronary Artery Disease | Atrial Fibrillation

Japan

Clinical Trials Sponsored by Daiichi Sankyo (China) Holdings Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations